<sup>18</sup>F-Fluoroethyl-L Tyrosine Positron Emission Tomography Radiomics in the Differentiation of Treatment-Related Changes from Disease Progression in Patients with Glioblastoma

<sup>18</sup>F-Fluoroethyl-L Tyrosine Positron Emission Tomography Radiomics in the Differentiation of Treatment-Related Changes from Disease Progression in Patients with Glioblastoma

The follow-up of glioma patients after therapeutic intervention remains a challenging topic, as therapy-related changes can emulate true progression in contrast-enhanced magnetic resonance imaging. <sup>18</sup>F-fluoroethyl-tyrosine (<sup>18</sup>F-FET) is a radiopharmaceuti...

Full description

Bibliographic Details
Main Authors: Begoña Manzarbeitia-Arroba, Marina Hodolic, Robert Pichler, Olga Osipova, Ángel Maria Soriano-Castrejón, Ana María García-Vicente
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
<sup>18</sup>F-fluoroethyl-tyrosine
positron emission tomography
radiomics
glioma tumor progression
treatment-related changes
Online Access:https://www.mdpi.com/2072-6694/16/1/195

Similar Items

Similar Items